Middeldorp S - Search Results

1

Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk score.

de Winter MA, Büller HR, Carrier M, Cohen AT, Hansen JB, Kaasjager KAH, Kakkar AK, Middeldorp S, Raskob GE, Sørensen HT, Visseren FLJ, Wells PS, Dorresteijn JAN, Nijkeuter M; VTE-PREDICT study group. de Winter MA, et al. Among authors: middeldorp s. Eur Heart J. 2023 Apr 7;44(14):1231-1244. doi: 10.1093/eurheartj/ehac776. Eur Heart J. 2023. PMID: 36648242 Free PMC article.

2

The incidence of venous thromboembolism in family members of patients with factor V Leiden mutation and venous thrombosis.

Middeldorp S, Henkens CM, Koopman MM, van Pampus EC, Hamulyák K, van der Meer J, Prins MH, Büller HR. Middeldorp S, et al. Ann Intern Med. 1998 Jan 1;128(1):15-20. doi: 10.7326/0003-4819-128-1-199801010-00003. Ann Intern Med. 1998. PMID: 9424976

3

Oral contraceptives and hormonal replacement therapy cause an imbalance in coagulation and fibrinolysis which may explain the increased risk of venous thromboembolism.

Levi M, Middeldorp S, Büller HR. Levi M, et al. Among authors: middeldorp s. Cardiovasc Res. 1999 Jan;41(1):21-4. doi: 10.1016/s0008-6363(98)00210-7. Cardiovasc Res. 1999. PMID: 10325950 No abstract available.

4

Increased risk for fetal loss in carriers of the factor V Leiden mutation.

Meinardi JR, Middeldorp S, de Kam PJ, Koopman MM, van Pampus EC, Hamulyák K, Prins MH, Büller HR, van der Meer J. Meinardi JR, et al. Among authors: middeldorp s. Ann Intern Med. 1999 May 4;130(9):736-9. doi: 10.7326/0003-4819-130-9-199905040-00013. Ann Intern Med. 1999. PMID: 10357692

5

Monitoring therapy with vitamin K antagonists in patients with lupus anticoagulant: effect on different tests for INR determination.

Bijsterveld NR, Middeldorp S, Berends F, Büller HR. Bijsterveld NR, et al. Among authors: middeldorp s. J Thromb Thrombolysis. 2000 Apr;9(3):263-9. doi: 10.1023/a:1018722829498. J Thromb Thrombolysis. 2000. PMID: 10728026

6

How to decide on the optimal duration of anticoagulatn therapy in carriers of the factor V Leiden mutation.

Middeldorp S, Büller HR. Middeldorp S, et al. Thromb Haemost. 2000 Nov;84(5):740-1. Thromb Haemost. 2000. PMID: 11127847 No abstract available.

7

The risk of pregnancy-related venous thromboembolism in women who are homozygous for factor V Leiden.

Middeldorp S, Libourel EJ, Hamulyák K, Van der Meer J, Büller HR. Middeldorp S, et al. Br J Haematol. 2001 May;113(2):553-5. doi: 10.1046/j.1365-2141.2001.02766.x. Br J Haematol. 2001. PMID: 11380431 Free article.

8

[No indication for thrombophilia screening in patients with idiopathic venous thromboembolism and their relatives].

Middeldorp S, Prins MH, Büller HR. Middeldorp S, et al. Ned Tijdschr Geneeskd. 2001 Jun 2;145(22):1047-51. Ned Tijdschr Geneeskd. 2001. PMID: 11414164 Review. Dutch.

9

A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism.

Middeldorp S, Meinardi JR, Koopman MM, van Pampus EC, Hamulyák K, van Der Meer J, Prins MH, Büller HR. Middeldorp S, et al. Ann Intern Med. 2001 Sep 4;135(5):322-7. doi: 10.7326/0003-4819-135-5-200109040-00008. Ann Intern Med. 2001. PMID: 11529695

10

Risk of venous thromboembolism in carriers of factor V Leiden with a concomitant inherited thrombophilic defect: a retrospective analysis.

Meinardi JR, Middeldorp S, de Kam PJ, Koopman MM, van Pampus EC, Hamulyák K, Prins MH, Büller HR, van der Meer J. Meinardi JR, et al. Among authors: middeldorp s. Blood Coagul Fibrinolysis. 2001 Dec;12(8):713-20. doi: 10.1097/00001721-200112000-00014. Blood Coagul Fibrinolysis. 2001. PMID: 11734673

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

474 results

Search Page

Filters